4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-019521
EVP, Research & CSO sold 5,560 shares at $44.80 ($249,086)
- EVP, Research & CSO acquired 5,560 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-09 | Exercise or conversion : show line 1 in the form | +5,560 | $1.53 | $8,507 | 79,760 | D |
| 2021-03-09 | Sale : show line 2 in the form | −5,560 | $44.80 | $249,086 | 74,200 | D |
| Open-market sales · 5,560 sh · avg $44.80 · $249,086 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-09 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −5,560 | 347,795 | D |
Loading xslF345X03/doc4.xml…